Big Options Gainers, New Ideas & More

SPY, PEP Options Reviews: 

Yesterday morning, in addition to providing an update on our running idea in the Pepsi options chain, we also included a fresh idea in the SPY. The markets ripped into the close, and facilitated some excellent intraday gain chances for both the PEP targets as well as our SPY ideas.

We’ve got fresh new highs on all of those, and in addition to a couple of earnings plays for new interests today, we’re also going to roll up to include some higher strike points for the SPY. Here are the two day gains on PEP and the single session moves on yesterday’s SPY calls:

PEP Weekly $149-152.50 Calls
$149:
 1.84-6.12 (+232%)
$150: 1.19-4.95 (+316%)
$152.50: .28-2.84 (+914%)
______

SPY 10/08 $430-431 Calls
$430:
 2.24-6.19 (+176%)
$431: 1.82-5.44 (+199%)

The markets look primed for more interesting activity as we head into week’s end, so as we mentioned above, we’rte going to roll up on the SPY to include tomorrow’s 10/08 $436-438 Calls.


Fresh Options Ideas:
HELE 10/15 $220-230 Calls
LEVI 10/15 $25-26 Calls 


Cyber Apps World, Inc. CYAP – Review: 

Lastly, we have to circle back for an OTC update on CYAP, a stock we tagged in Tuesday’s premarket report. It has posted new highs, broken through from subpenny to penny stock pricing, and reached double-bag status.

Our observed low on CYAP Tuesday was .0052, and as of yesterday’s top mark of .0125, that represents an overnight run of 140%


Extended Watchlist:
CEI, BBIG, CYRN, NURO, AMLH, VBHI, IFXY, SPZI, BNOW, CGAC

Options Recaps, Fresh Ideas & More

Final 09/22 SPY Calls Review:

As we were just mentioning yesterday morning, our tag of the SPY 09/22 $436-438 Calls in Tuesday’s premarket report, provided us with some very nice opportunities. We reported Tuesday’s gains on these contracts that expired yesterday afternoon, and cautioned that they could very well register new highs before the end of the day. That’s precisely what occurred, as the S&P made sharp advances right from the opening bell.

Slightly larger gains could have been available intraday if you *only* caught yesterday’s report, but the following figures represent the largest possible gains for those who may have taken an interest on the previous morning of our initial alert:

SPY 09/22 $436-438 Calls
$436: 1.51-4.18 (+177%)
$437: 1.15-3.25 (+183%)
$438: .84-2.42 (+188%)
_____

We also had a pair of fresh options trading ideas in yesterday morning’s report, in the form of the SFIX Weekly $38-41 Calls and the GIS 10/15 $55-60 Calls. Both of those ideas returned instant gratification in the form of the following intraday moves:

SFIX Weekly $38-41 Calls
$38:
 2.60-4.20 (+62%)
$39: 2.00-3.55 (+78%)
$40: 1.56-2.77 (+78%)
$41: 1.08-2.22 (+106%)
_____

GIS 10/15 $55-60 Calls
$55: 3.80-5.50 (+45%)
$57.50: 1.70-3.40 (+100%)
$60: .60-1.42 (+137%)


Fresh Options Ideas:
DRI 10/15 $155-160 Calls
ACN Weekly $337.50-342.50 Calls 


Extended Watchlist:
TONR, PJET, TGGI, ETEK, CFGX, WDLF, EEGI, MRM, AMHC, RNAZ, DBGI, NURO, FEDU

MDGS News, Options Plays & More

Medigus Ltd. MDGS – News Alert:

Our first order of business today is to go over the fresh news to hit the wires this morning for MDGS, One of the companies in which MDGS owns a controlling stake, is reporting that its Capture and Contain (C&C™) platform technology has been found effective in reducing the risk of infection with the H1N1 virus. Polyrizon has already reported similar results with coronavirus.

MDGS was the subject a special report we published on Monday morning. We’d suggest any of our readers who may have missed it, click here and go check it out. The stock has established higher lows each session this week, and it seems we timed the bottom with striking accuracy. Considering the frequency with which promising developments have been occurring for MDGS and its interests, like Polyrizon, we’re eager to see where this stock can go from here.
_____

OMER, Israel, Aug. 27, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, presented pre-clinical data showing that its Capture and Contain (C&C™) platform technology has the potential to reduce the risk of an infection with Influenza virus H1N1 and may potentially also treat additional Cold viruses.(>>Read Full PR)
_____

To Learn More about MDGS Please Visit:
Medigus.com/Investor-Relations


Options Review:

Two out of yesterday’s three fresh options ideas were quick strike post-earnings plays, the  ULTA Weekly $405-415 Calls and the CRM Weekly $262.50-270 Calls, and they both provided ample opportunity for solid daily gains.

ULTA Weekly $405-415 Calls
$405:
 2.66-8.58 (+222%)
$410: 2.51-6.76 (+169%)
$415: 1.88-8.72 (+364%)
______

CRM Weekly $262.50-270 Calls
$262.50: 7.74-12.95 (+67%)
$265: 5.92-10.55 (+78%)
$267.50: 4.60-8.10 (+76%)
$270: 3.31-5.92 (+79%)
_____

Fresh Options Ideas:
HIBB 09/17 $100-105 Calls
GPS Weekly $27-28.50 Calls*
WDAY Weekly $255-270*

*Please don’t attempt to trade weekly options on a Friday unless you are an experienced trader with access to disposable funds!


Extended Watchlist:
SPRT, NURO, RNXT, CEMI, NNA, PRFX, CLNV, BRBP, ICOA, SRCO, BRNE